Senores Pharmaceuticals Declares Unaudited Q2 FY27 Results

Senores Pharmaceuticals Limited announced its unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, along with the Limited Review Reports from statutory auditors Pankaj R. Shah and Associates. Additionally, the company appointed M/s Talati and Talati LLP as Joint Statutory Auditors for the period 2026-27 to 2030-31, alongside the existing auditors.